On the World Day of the Fight against Alzheimer's, experts recommend exercising the mind, learn new skills and do accompanied activities. Today, in Argentina there are 500,000 people diagnosed with Alzheimer's Disease and while there are no drugs, vaccines or curative therapies to treat it, there is a novel biotechnological compound called Cerebrolysin, developed in Austria, which is already approved and available in our country. A study carried out by a group of 11 physicians and with about 204 patients, showed an improvement in 70% of the cases, primarily in cognition and activities of daily living. On the side of the family and caregivers, data from 197 patients were obtained, yielding a significant improvement in the evaluation of two scales referring to activities of daily living and cognitive impairment. The subjective impression was positive (good and very good) in 77% of cases.